House Dust Mite Rhinitis: Clinical Trials

1 trial for House Dust Mite Rhinitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow House Dust Mite Rhinitis: new trials by email Literature Review of House Dust Mite Rhinitis trials Research Report on House Dust Mite Rhinitis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
PURETHAL Mites 50,000 AUeq/ml, Biological/Vaccine: Placebo - House Dust Mite Allergy, House Dust Mite Rhinitis
Phase 3CompletedHAL Allergy6912024-09-092026-08-10

Narrower conditions

Dust Mite Allergy (1)  ·  Hypersensitivity (1)  ·  Rhinitis (1)

Broader conditions

Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Infections (1)  ·  Nose Diseases (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Respiratory Hypersensitivity (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Rhinitis, Allergic (1)  ·  Rhinitis, Allergic, Perennial (1)

Interventions

Biological Products (1)

Sponsors

HAL Allergy (1)

Countries

Bulgaria (1)  ·  Germany (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Poland (1)

Top investigators

Hans Hoogeveen (1)

NIH funding

2023 (1)